Related Experiment Video
Updated: Jan 22, 2026

Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and
Noemí Cabré1, Fedra Luciano-Mateo1, Salvador Fernández-Arroyo1
1Department of Medicine and Surgery, Universitat Rovira i Virgili, Reus, Spain; Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus, Spain.
Background & Aims:
Hepatic alterations, such as in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are frequently associated with obesity. To investigate the molecular mechanisms of these alterations and to identify molecules that could be used as potential therapeutic targets, we investigated the modulation of hepatic indices of oxidative stress and inflammation in obese patients undergoing laparoscopic sleeve gastrectomy (LSG).
Methods:
Patients (n = 436) attending our obesity clinic underwent LSG for weight loss. We obtained a diagnostic intraoperative liver biopsy, and a sub-cohort (n = 120) agreed to a 1-year follow-up that included donation of blood samples and additional liver biopsies. Selected key molecules in blood and liver tissue were used to investigate the hepatic alterations in obesity, and their response to LSG.
Results:
One year post-surgery, the prevalence of diabetes, dyslipidemia and hypertension decreased significantly. LSG improved liver histology features in all patients. Improvement was greater in severe cases of NAFLD including those with steatohepatitis, bridging fibrosis or cirrhosis. Significant pre-surgery differences in plasma, and liver markers of oxidative stress and inflammation (including chemokine C-C motif ligand 2, paraoxonase-1, galectin-3, and sonic hedgehog) were observed between patients with, and those without, NASH; post-surgery indicated consistent improvements in these parameters.
Conclusion:
Our study shows that the histology and liver function of patients with morbid obesity are significantly improved after LSG via mechanisms that involve the reduction of oxidative stress and inflammatory processes. These data encourage the use of LSG as a therapeutic option to improve, or resolve, NAFLD.
Insights
Laparoscopic sleeve gastrectomy (LSG) significantly improves liver health in obese patients by reducing oxidative stress and inflammation. This procedure offers a promising therapeutic option for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Area of Science:
- Hepatology
- Bariatric Surgery
- Metabolic Syndrome
Background:
- Obesity is strongly linked to hepatic alterations like non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
- Understanding the molecular mechanisms driving these liver conditions in obesity is crucial for developing effective treatments.
- Investigating the impact of bariatric surgery on these mechanisms offers a potential therapeutic avenue.
Purpose of the Study:
- To investigate the molecular mechanisms underlying hepatic alterations in morbidly obese patients.
- To assess the modulation of hepatic oxidative stress and inflammation markers following laparoscopic sleeve gastrectomy (LSG).
- To identify potential therapeutic targets for NAFLD and NASH in the context of obesity surgery.
Main Methods:
- A cohort of 436 obese patients underwent LSG, with liver biopsies obtained intraoperatively.
- A sub-cohort of 120 patients provided blood samples and liver biopsies at a 1-year follow-up.
- Key molecular markers of oxidative stress and inflammation in blood and liver tissue were analyzed pre- and post-LSG.
Main Results:
- LSG led to significant improvements in liver histology, particularly in severe cases of NAFLD, NASH, fibrosis, and cirrhosis.
- Post-surgery, there were significant reductions in the prevalence of diabetes, dyslipidemia, and hypertension.
- Key plasma and liver markers of oxidative stress and inflammation, including chemokine C-C motif ligand 2, paraoxonase-1, galectin-3, and sonic hedgehog, showed consistent improvement post-LSG.
Conclusions:
- LSG significantly improves liver histology and function in morbidly obese patients.
- The beneficial effects of LSG are mediated through the reduction of oxidative stress and inflammatory processes.
- LSG is a viable therapeutic option for improving or resolving NAFLD and associated complications.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
Related Concept Videos
Oxidation of Alcohols
The process of oxidation in a chemical reaction is observed in any of the three forms:
Radical Oxidation of Allylic and Benzylic Alcohols
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Inflammation
Responses to Heat and Cold Stress
Oxidation Numbers